CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 76 enrolled
Drug / intervention
Transcranial magnetic stimulationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04263766
NCT04263766N/ACompleted

The Role of Different Prefrontal Areas in Visual Metacognition

Georgia Institute of Technology·interventional·Posted Feb 11, 2020·Updated Sep 15, 2023

In Brief

A clinical study evaluating Transcranial magnetic stimulation for Healthy. Completed, enrolled 76 participants across 1 site.

Detailed Summary

The study will use transcranial magnetic stimulation (TMS) to investigate the causal role of different brain regions during visual perception. TMS is a well-established technique used by hundreds of labs in the world. The risks associated with the technique are well understood and can be minimized by strict adherence to established safety guidelines. In the proposed study, the investigators will use TMS to specifically address the topic of how metacognitive evaluation is supported by the two prefrontal areas: the dorsolateral prefrontal cortex (DLPFC) and the anterior prefrontal cortex (aPFC). The data will be collected from healthy adults and will ultimately deepen the investigator's understanding of the mechanisms behind the normal processes related to confidence generation and metacognition.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 11, 2020
Enrollment StartFeb 22, 2022
Primary CompletionAug 31, 2022
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 6.4 years ago

Interventions

Transcranial magnetic stimulationother

TMS will be delivered to different brain areas in order to establish their contribution to visual metacognition.